Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 129

1.

Changes in QTc interval in the citalopram for agitation in Alzheimer's disease (CitAD) randomized trial.

Drye LT, Spragg D, Devanand DP, Frangakis C, Marano C, Meinert CL, Mintzer JE, Munro CA, Pelton G, Pollock BG, Porsteinsson AP, Rabins PV, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG; CitAD Research Group.

PLoS One. 2014 Jun 10;9(6):e98426. doi: 10.1371/journal.pone.0098426. eCollection 2014.

PMID:
24914549
[PubMed - in process]
Free PMC Article
2.

Overrepresentation of glutamate signaling in Alzheimer's disease: network-based pathway enrichment using meta-analysis of genome-wide association studies.

Pérez-Palma E, Bustos BI, Villamán CF, Alarcón MA, Avila ME, Ugarte GD, Reyes AE, Opazo C, De Ferrari GV; Alzheimer's Disease Neuroimaging Initiative; NIA-LOAD/NCRAD Family Study Group.

PLoS One. 2014 Apr 22;9(4):e95413. doi: 10.1371/journal.pone.0095413. eCollection 2014.

PMID:
24755620
[PubMed - in process]
Free PMC Article
3.

Automatic ROI selection in structural brain MRI using SOM 3D projection.

Ortiz A, Górriz JM, Ramírez J, Martinez-Murcia FJ; Alzheimer's Disease Neuroimaging Initiative.

PLoS One. 2014 Apr 11;9(4):e93851. doi: 10.1371/journal.pone.0093851. eCollection 2014.

PMID:
24728041
[PubMed - in process]
Free PMC Article
4.

Testing for association with multiple traits in generalized estimation equations, with application to neuroimaging data.

Zhang Y, Xu Z, Shen X, Pan W; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2014 Aug 1;96:309-25. doi: 10.1016/j.neuroimage.2014.03.061. Epub 2014 Apr 1.

PMID:
24704269
[PubMed - in process]
5.

Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment.

Mattsson N, Tosun D, Insel PS, Simonson A, Jack CR Jr, Beckett LA, Donohue M, Jagust W, Schuff N, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.

Brain. 2014 May;137(Pt 5):1550-61. doi: 10.1093/brain/awu043. Epub 2014 Mar 12.

PMID:
24625697
[PubMed - indexed for MEDLINE]
6.

Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial.

Porsteinsson AP, Drye LT, Pollock BG, Devanand DP, Frangakis C, Ismail Z, Marano C, Meinert CL, Mintzer JE, Munro CA, Pelton G, Rabins PV, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG; CitAD Research Group.

JAMA. 2014 Feb 19;311(7):682-91. doi: 10.1001/jama.2014.93.

PMID:
24549548
[PubMed - indexed for MEDLINE]
7.

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.

Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators.

N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839.

PMID:
24450891
[PubMed - indexed for MEDLINE]
8.

Depression and risk of dementia: exploring the interface.

Porsteinsson AP, Antonsdottir IM.

J Clin Psychiatry. 2013 Dec;74(12):1262-3. doi: 10.4088/JCP.13com08787. No abstract available.

PMID:
24434096
[PubMed - indexed for MEDLINE]
9.

Effects of baseline CSF α-synuclein on regional brain atrophy rates in healthy elders, mild cognitive impairment and Alzheimer's disease.

Mattsson N, Insel P, Tosun D, Zhang J, Jack CR Jr, Galasko D, Weiner M; Alzheimer’s Disease Neuroimaging Initiative.

PLoS One. 2013 Dec 31;8(12):e85443. doi: 10.1371/journal.pone.0085443. eCollection 2013.

PMID:
24392009
[PubMed - in process]
Free PMC Article
10.

Is sertraline treatment or depression remission in depressed Alzheimer patients associated with improved caregiver well being? Depression in Alzheimer's disease study 2.

Flynn Longmire CV, Drye LT, Frangakis CE, Martin BK, Meinert CL, Mintzer JE, Munro CA, Porsteinsson AP, Rabins PV, Rosenberg PB, Schneider LS, Weintraub D, Lyketsos CG; DIADS-2 Research Group.

Am J Geriatr Psychiatry. 2014 Jan;22(1):14-24. doi: 10.1016/j.jagp.2013.02.014.

PMID:
24314887
[PubMed - in process]
11.

The law of diminishing intent: getting excited about apathy.

Porsteinsson AP, Hasselberg MJ.

J Clin Psychiatry. 2013 Aug;74(8):817-8. doi: 10.4088/JCP.13com08574. No abstract available.

PMID:
24021499
[PubMed - indexed for MEDLINE]
12.

Mapping the genetic variation of regional brain volumes as explained by all common SNPs from the ADNI study.

Bryant C, Giovanello KS, Ibrahim JG, Chang J, Shen D, Peterson BS, Zhu H; Alzheimer's Disease Neuroimaging Initiative.

PLoS One. 2013 Aug 28;8(8):e71723. doi: 10.1371/journal.pone.0071723. eCollection 2013.

PMID:
24015190
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

The impact of AD drug treatments on event-related potentials as markers of disease conversion.

Chapman RM, Porsteinsson AP, Gardner MN, Mapstone M, McCrary JW, Sandoval TC, Guillily MD, Reilly LA, DeGrush E.

Curr Alzheimer Res. 2013 Sep;10(7):732-41.

PMID:
23905997
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Deformable templates guided discriminative models for robust 3D brain MRI segmentation.

Liu CY, Iglesias JE, Tu Z; Alzheimer's Disease Neuroimaging Initiative.

Neuroinformatics. 2013 Oct;11(4):447-68. doi: 10.1007/s12021-013-9190-5.

PMID:
23836390
[PubMed - indexed for MEDLINE]
15.

Improved inference in Bayesian segmentation using Monte Carlo sampling: application to hippocampal subfield volumetry.

Iglesias JE, Sabuncu MR, Van Leemput K; Alzheimer’s Disease Neuroimaging Initiative.

Med Image Anal. 2013 Oct;17(7):766-78. doi: 10.1016/j.media.2013.04.005. Epub 2013 May 22.

PMID:
23773521
[PubMed - indexed for MEDLINE]
16.

CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology.

Bradshaw EM, Chibnik LB, Keenan BT, Ottoboni L, Raj T, Tang A, Rosenkrantz LL, Imboywa S, Lee M, Von Korff A; Alzheimer Disease Neuroimaging Initiative, Morris MC, Evans DA, Johnson K, Sperling RA, Schneider JA, Bennett DA, De Jager PL.

Nat Neurosci. 2013 Jul;16(7):848-50. doi: 10.1038/nn.3435. Epub 2013 May 23.

PMID:
23708142
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

The receiver operational characteristic for binary classification with multiple indices and its application to the neuroimaging study of Alzheimer's disease.

Wu X, Li J, Ayutyanont N, Protas H, Jagust W, Fleisher A, Reiman E, Yao L, Chen K; Alzheimer's Disease Neuroimaging Initiative.

IEEE/ACM Trans Comput Biol Bioinform. 2013 Jan-Feb;10(1):173-80. doi: 10.1109/TCBB.2012.141.

PMID:
23702553
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Functional activity maps based on significance measures and Independent Component Analysis.

Martínez-Murcia FJ, Górriz JM, Ramírez J, Puntonet CG, Illán IA; Alzheimer's Disease Neuroimaging Initiative.

Comput Methods Programs Biomed. 2013 Jul;111(1):255-68. doi: 10.1016/j.cmpb.2013.03.015. Epub 2013 May 6.

PMID:
23660005
[PubMed - indexed for MEDLINE]
19.

Brain changes in older adults at very low risk for Alzheimer's disease.

Fjell AM, McEvoy L, Holland D, Dale AM, Walhovd KB; Alzheimer's Disease Neuroimaging Initiative.

J Neurosci. 2013 May 8;33(19):8237-42. doi: 10.1523/JNEUROSCI.5506-12.2013.

PMID:
23658162
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Generative FDG-PET and MRI model of aging and disease progression in Alzheimer's disease.

Dukart J, Kherif F, Mueller K, Adaszewski S, Schroeter ML, Frackowiak RS, Draganski B; Alzheimer's Disease Neuroimaging Initiative.

PLoS Comput Biol. 2013 Apr;9(4):e1002987. doi: 10.1371/journal.pcbi.1002987. Epub 2013 Apr 4.

PMID:
23592957
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk